Search

everythinglearnresearchcommunity

for

Search:↓

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Hair loss from weight-loss treatments is usually temporary and reversible.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

Trichobiolight effectively treats hair loss with 82.5% success.

FAGA shows varied hair thickness, while TE has more empty follicles.

The drinkable supplement increased hair growth and was safe for women with hair loss.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Rosmarinus officinalis tincture significantly improves hair volume and density.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

Hair loss can be an early sign of Crohn's disease in children.

UV rays can cause a type of hair loss known as telogen alopecia.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.